X @Bloomberg
Bloomberg·2025-10-20 17:58
Summit Therapeutics plans to file for approval for its closely watched lung cancer treatment by the end of this year, even though US drug regulators already warned the company it doesn’t have strong enough data https://t.co/x1Wm9t8fAB ...